Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers
- Biosens. Bioelectron., May 01 2024, 258 S0956-5663(24)00352-X | https://doi.org/10.1016/j.bios.2024.116347